Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Will the Year of Wooden Sheep Bring Positive Changes to Chinese Pharma?
Comprehensive annual review and outlook of China's pharma and healthcare sector by Pharma China Publisher and Chief Editor James Shen.... (1/20/2015)
   
Will the Year of Wooden Sheep Bring Positive Changes to Chinese Pharma? (1/20/2015)
China Works To Regulate The Difference Between Food And Traditional Chinese Medicine (1/15/2015)
What Does 2015 Have In Store For China's Healthcare Economy? (1/14/2015)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2014 (1/12/2015)
China Pharmaceutical Pricing Policy: Painful Reform, High Cost, But Promising (12/31/2014)
2014: The Top Ten Stories In China's Health Sector (External) (12/30/2014)
Urgent Notice from Pharma China Team (12/28/2014) (free)
Challenges and Opportunities Ahead as the Government Mulls Change to Rules of the Game (12/25/2014)
China's Health Food Reforms Offer More Proposals than Solutions (12/15/2014)
China's Evolving Pharma Partnering Landscape: The Right Partner Profile (12/12/2014)
Foreign Drug Companies in China See Approval Delays (External) (12/8/2014)
Top 5 MCM Trends in China, Emerging Markets and Japan (12/2/2014)
China Daily: Drug Firms Seek New Strategies (External) (11/30/2014)
China Issues Draft Guidance On Multi-Regional Clinical Trials (11/27/2014)
NDRC's Ill-fated Drug Price Reform Path and Latest Proposal to Exit (11/27/2014)
New CFDA Minister Appointed  (1/27/2015) (free)
EU Withdraws GMP Certification of NCPC S...  (1/27/2015)
MOHRSS Outlines Healthcare Reform Tasks ...  (1/26/2015)
CFDA Issues Draft Hospital Drug Formulat...  (1/26/2015)
89 Pharma Distributors in Hubei Petition...  (1/26/2015)
Pharma-related Tasks Highlighted in NHFP...  (1/26/2015)
ADI: China to See 30 Million Dementia Ca...  (1/26/2015)
GSK Denies Imminent Job Cuts in China  (1/26/2015)
3SBio Acquires Italian CMO Sirton Pharma...  (1/26/2015)
Echo Therapeutics and MTIA Re-establishe...  (1/23/2015)
CITIC Bank Lines Up with Alibaba Health ...  (1/23/2015)
Financial-related Company News in Brief  (1/23/2015)
Innovent Biologics Raises US$100M from S...  (1/23/2015)
Recent Executive Moves  (1/22/2015)
Perkin Elmer Opens New Medical Laborator...  (1/21/2015)
GlobalData: Pharma Cos to Lose $65B by 2019 Due To Paten...
Deloitte: Returns on Pharma R&D Improving as Pipelin...
Improving Access to Medicine in Developing Countries
2014 The Most Active Year for Healthcare Deals in Two De...
CSDD: Cost to Develop A New Drug Now Exceeds US$2.5B
China Leads APAC's Type 2 Diabetes Drug Market Growth Before 20...
BMI Releases China Pharmaceuticals and Healthcare Report Q12015...
Urban Hospital Drug Market in 1H/2014: Leading Products and Sup...
Kantar Reports on Biosimilar Market Access and Barriers in Chin...
Chinese Animal Vaccine Market Expect to Rise 15% Annually Befor...
ADI: China to See 30 Million Dementia Cases by 2050
GSK Denies Imminent Job Cuts in China
3SBio Acquires Italian CMO Sirton Pharma
Echo Therapeutics and MTIA Re-establishes Partnership for Ch...
CITIC Bank Lines Up with Alibaba Health to Build Pharma e-Co...
CFDA Issues Draft Hospital Drug Formulation Regulation f...
CFDA Issued 478 New Drug Approvals in 2014
NHFPC Announces 18 Domestic New Drugs Recommended for Pr...
China to Issue Stem Cell Regulations and Support Policie...
CFDA Lays Out Its Regulatory Plan for 2015
VellPharm Wins Lawsuit Against CFDA over Registration Proced...
USTR Releases 2014 Report on China's WTO Compliance Highligh...
China Makes Pledges on Pharma Business, Enforcement and IP a...
Two Medical Reps Handed Jail Sentences with Probation in Sha...
Fujifim to Sue Sihuan Pharma over IP Infringements Related t...
EU Withdraws GMP Certification of NCPC Subsidiary
USFDA Issues Warning Letter to Chinese API Producer Nova...
Lonza to Manufacture Sunshine Biopharma's Novel Anticanc...
Baiyunshan, Alkpharm to Join Hands for API Manufacturing...
UniTao Pharma Buys Boehringer Ingelheim's API Facility i...
Chinese Researchers Launch Clinical Trial of Stem Cell T...
CFDA Approves the World's First Sabin IPV
Citeline Launches China Clinical Trial Solution
Sirnaomics and Xiangxue Pharma File IND for Anti-Fibrosi...
TWi Granted Key Chinese Patent for Its Novel Diabetes Dr...
MOHRSS Outlines Healthcare Reform Tasks in 2015
89 Pharma Distributors in Hubei Petition Against New Pol...
Pharma-related Tasks Highlighted in NHFPC's 2015 Health ...
State Council Passes New Policy to Optimize Healthcare R...
NHFPC Plans Price Negotiation Mechanism for Drug Product...
New CFDA Minister Appointed
Recent Executive Moves
Recent Executive Moves
Chairman of PKU Pharma Taken Away for Insider Trading Inve...
Recent Executive Moves
Upcoming Event: Pharma China Annual Forum 2015 on March ...
China to Launch $6.5B State-backed VC Fund Supporting St...
Upcoming Event: Asia Pacific Pharma Congress
Upcoming Event: Pharmaceutical Compliance
Upcoming Event: 7th Annual AsiaTIDES
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links